EBOSF (Ebos Group) Accumulated Depreciation: $0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EBOSF Ebos Group Ltd EBOSF
85 GF Score
Price $23.75
GF Value $43.41
! 4 Warning Signs
View Full Analysis

What is Ebos Group Accumulated Depreciation?

Ebos Group EBOSF +15.85% 85 Accumulated Depreciation is $0 Mil as of Dec. 2025. GuruFocus rates EBOSF with a GF Score™ of 85/100 and a GF Value™ of $43.41. The stock has 4 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Ebos Group's quarterly accumulated depreciation increased from Dec. 2024 ($0 Mil) to Jun. 2025 ($-277 Mil) but then stayed the same from Jun. 2025 ($-277 Mil) to Dec. 2025 ($0 Mil).

Ebos Group's annual accumulated depreciation increased from Jun. 2023 ($-185 Mil) to Jun. 2024 ($-235 Mil) and increased from Jun. 2024 ($-235 Mil) to Jun. 2025 ($-277 Mil).

Ebos Group Accumulated Depreciation Related Terms

Ebos Group Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Ebos Group's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ebos Group Accumulated Depreciation Chart

Ebos Group Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -123.52 -151.57 -184.98 -234.93 -276.75

Ebos Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -234.93 0.00 -276.75 0.00
EBOSF
85GF Score
Ebos Group Ltd EBOSF
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ebos Group Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of $0 Mil mean?
Ebos Group (EBOSF) has a Accumulated Depreciation of $0 Mil as of Dec. 2025. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Ebos Group and its competitors.
Is Ebos Group's Accumulated Depreciation too high?
Ebos Group's current Accumulated Depreciation is $0 Mil. Overall, Ebos Group has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Ebos Group's Accumulated Depreciation compare to MCK and COR?
Ebos Group's Accumulated Depreciation of $0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Medical Distribution company?
A good Accumulated Depreciation depends on the Medical Distribution industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Ebos Group and its competitors. Ebos Group's current Accumulated Depreciation is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ebos Group stock overvalued right now?
Ebos Group (EBOSF) has a current Accumulated Depreciation of $0 Mil. The stock's GF Value™ is $43.41, compared to a current price of $23.75 — trading 45.3% below its estimated fair value. The current Accumulated Depreciation is $0 Mil. Ebos Group's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Ebos Group (EBOSF), the current Accumulated Depreciation is $0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ebos Group (EBOSF) Overvalued in 2026?

Based on GuruFocus' analysis, Ebos Group stock appears to be undervalued. The current stock price of $23.75 is trading 45.3% below its estimated GF Value™ of $43.41.

Key valuation signals for EBOSF:

  • Accumulated Depreciation: $0 Mil
  • GF Value™: $43.41 vs. price of $23.75 (45.3% below fair value)
  • GF Score™: 85/100 with 4 warning signs

No single metric tells the full story. See the EBOSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ebos Group Business Description

Address 737 Bourke Street, Level 7, Docklands, Melbourne, VIC, AUS, 3008
Ebos is the largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
85GF Score

Get the complete analysis for EBOSF

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.75
Price
$43.41
GF Value